The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Studies have determined that Yasmin and Yaz, used for a form of birth control, are a defective product and are linked to risk of blood clots. Patients who are on the drug are 3 times more likely to develop a blood clot, according to a Health Canada review. The harmful drug was identified as drospirenone.

“Overall, the body of evidence suggests that the risk of blood clots in 1.5 to 3 times higher with oral contraceptives that contain drospirenone relative to those that contain levonorgestrel, a different hormone,” says the report. “To put this in perspective, if the estimated risk of developing a blood clot among women taking a levonorgestrel-containing birth control pill is 1 in 10,000 women per year, as some studies have estimated, then the risk in women taking a drospiernone birth control pill is about 1.5 to 3 women in 10,000 per year.”

The drug labels have been altered to show the findings.

Has a defective product injured you or a loved one?

Wooten, Kimbrough & Normand, P.A.—Orlando personal injury attorneys.

Comments are closed.

Of Interest